Last Updated on October 10, 2024 by The Health Master
The Indian Pharmacopoeia Commission (IPC) has published draft monograph revision proposals for stakeholders’ recommendations and comments by February 20, 2023.
These are to be included in Indian Pharmacopoeia (IP) Addendum 2024 with tentative effective date of April, 2024.
IP Addendum is published by the IPC on behalf of the Union health ministry in fulfillment of the requirements of the Drugs and Cosmetics Act, 1940 and Rules 1945 thereunder.
A monograph is a written document that reflects the quality attributes of medicines approved by the drug regulator.
IPC has urged the stakeholders to submit suggestions, feedback, or comments at lab.ipc@gov.in.
IPC is an autonomous institution under the Union health ministry to deal with matters relating to timely publication of the IP which is the official book of standards for drugs to specify the standards of identity, purity, and strength of the drugs imported, manufactured for sale, stocked, or exhibited for sale or distributed in India.
“IPC has published 8 new monographs for public comment. “Till date, a total of 64 monographs have been published under the category of pharmaceuticals and veterinary monographs,” informed Dr Rajiv Singh Raghuvanshi, secretary-cum-scientific director, IPC.
IP is a compilation of official standards for drugs manufactured and/or marketed in India. A monograph specifies the quality or test parameters, the acceptance criteria, and the tests to be performed to determine if the criteria are met.
IP is recognized as the official book of standards for the drugs being manufactured and/or marketed in India.
IP contains a collection of authoritative procedures of analysis and specifications of drugs for their identity, purity and strength.
The standards of the IP are authoritative in nature and are enforced by the regulatory authorities for ensuring the quality of drugs in India.
During quality assurance and at the time of dispute in the court of law, the IP standards are legally acceptable.
Veterinary Monographs as under:
- Carpofen Tablets
- Pimobendan (version 2.0; 05.01.2023)
- Pimobendan Capsules (version 2.0; 05.01.2023)
- Selamectin (vet) (version 2.0; 19.12.2022)
- Tilmicosin
- Tilmicosin Injection (vet) (version 2.0; 19.12.2022)
- Triclabendazole
- Monographs referred from Volume II and Volume III of IP
- Cephapirin Benzathine (28.11.2022)
- Cephapirin Benzathine Intramammary Infusion (28.11.2022)
- Tilmicosin Phosphate (05.01.2023)
- Flunixin Meglumine Injection (05.01.2023)
Union minister for health and chemicals and fertilisers Dr. Mansukh Mandaviya released the ninth edition of IP on July 1 at Vigyan Bhawan, New Delhi.
IP 2022 contains a total of:
- 92 new monographs including 60 chemical,
- 21 vitamins, minerals, amino acids, fatty acids etc.,
- 3 biotechnology-derived therapeutic products,
- 4 human vaccines,
- 2 blood and blood related products,
- 2 herbs and herbal related products,
- 7 phytopharmaceutical ingredient category monographs.
This has led to the total number of 3152 monographs in the current edition of IP.
In addition, 12 new general chapters have also been introduced. Several monographs and general chapters have also been revised to update them as per current global requirements and to harmonize with other pharmacopoeias like US Pharmacopoeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), etc.
The harmonization of standards with global standards is expected to help IP get recognized and accepted in foreign countries.
Latest Circulars: (IPC) Indian Pharmacopoeia Commission
Latest Notifications regarding Pharmaceuticals
Latest on National Formulary of India (NFI)
Online purchase: procedure
Books: IP and NFI
Rates-and-Procedure-to-purchase-of-different-volumes-of-IP-and-NFI
Click here to purchase Books: IP & NFI
IP Reference Substances
Click here to purchase IP Reference Substances
Impurity Standards
Click here to purchase Impurity Standards
Monographs
Pharmaceuticals Monograph
Click here for Pharmaceuticals Monograph
Veterinary Monograph
Click here for Veterinary Monograph
High demand for Indian generic drugs in China
NPPA may fix retail price of drugs under phase IV Clinical trials
Govt Job: For the post of Director at CDTL, CDSCO
List of approved FDCs (Fixed Dose Combinations) Updated
List of approved New Drugs Updated
NPPA extends ceiling price of LMO, Oxygen Inhalation
Drug recall: Daptomycin for Injection recalled due to this reason
New BCG vaccine for TB: Clinical trials to start soon
Drug licences of these two firms suspended: FDA Manipur
Fake pharma firm busted, two arrested
Latest Notifications regarding Pharmaceutical
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
